Vismodegib in Treating Patients With Advanced Chondrosarcomas
Vismodegib in Treating Patients With Advanced Chondrosarcomas
Active, not recruiting · NCT01267955 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Vismodegib in Treating Patients With Advanced Chondrosarcomas | Chondrosarcoma, Clear Cell, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, chondrosarcoma, connective tissue neoplasm, dedifferentiated chondrosarcoma, mesenchymal chondrosarcoma, neoplasm, sarcoma | Active, not recruiting | Phase 2 | 2026-08-13 | NCT01267955 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Leon Berard | Lyon | France | 70 |
| Centre Oscar Lambert | Lille | France | 3 |
| Gustave Roussy | Villejuif | France | 119 |
| Hopital de la Timone | Marseille | France | 11 |
| Institut Bergonie Cancer Center | Bordeaux | France | 3 |
| Institut Curie Paris | Paris | France | 8 |